Orally administered adenoviral-based vaccine induces respiratory mucosal memory and protection against RSV infection in cotton rats

Overview of attention for article published in Vaccine, June 2018

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

So far, Altmetric has seen 7 news stories from 7 outlets.

Vaxart, Inc. (Nasdaq:VXRT), a clinical-stage biotechnology company developing oral recombinant vaccines that are administered…

SOUTH SAN FRANCISCO, Calif.--(Business Wire)--Vaxart, Inc. (Nasdaq:VXRT), a clinical-stage biotechnology company developing…

Vaxart, Inc. (Nasdaq:VXRT), a clinical-stage biotechnology company developing oral recombinant vaccines that are administered…

-Vaxart, Inc. (Nasdaq:VXRT), a clinical-stage biotechnology company developing oral recombinant vaccines that are administered…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 3 additional news stories.